Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,583 INR | -0.02% | +0.71% | +19.69% |
06-17 | Lupin Appoints CEO for Subsidiary Lupin Manufacturing Solutions | MT |
06-14 | Lupin Gets Zero Observations from US FDA After Nagpur, India Unit Inspection | MT |
Business Summary
- design and production of generic and brand-name formulations;
- production of active pharmaceutical ingredients.
At the end of March 2022, the group had 15 production sites India (12), the United States, Mexico and Brazil.
Net sales break down geographically as follows: India (39.4%), the United States (34.1%) and other (26.5%).
Number of employees: 20,933
Sales per Business
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 164,055 | 100.0 % | 166,417 | 100.0 % | +1.44% |
Sales per region
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
India
40.0
%
| 64,596 | 39.4 % | 66,507 | 40.0 % | +2.96% |
United States
31.0
%
| 56,352 | 34.3 % | 51,584 | 31.0 % | -8.46% |
Others
29.0
%
| 43,107 | 26.3 % | 48,326 | 29.0 % | +12.11% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | 31/12/96 | |
Johnny Mikell
PSD | President | - | - |
Director of Finance/CFO | 59 | 12/08/07 | |
Shahin Fesharaki
CTO | Chief Tech/Sci/R&D Officer | - | - |
Compliance Officer | - | - | |
Director/Board Member | 50 | 31/12/95 | |
Ravik Agarwal
IRC | Investor Relations Contact | - | - |
Jon Stelzmiller
PRN | Corporate Officer/Principal | - | - |
Rajeev Sibal
PRN | Corporate Officer/Principal | - | - |
Yashwant Mahadik
HRO | Human Resources Officer | - | 09/07/18 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 74 | 26/10/15 | |
Mark McDade
BRD | Director/Board Member | 69 | 27/01/21 |
Director/Board Member | 50 | 31/12/95 | |
Chairman | 80 | 28/02/83 | |
Director of Finance/CFO | 59 | 12/08/07 | |
Chief Executive Officer | 56 | 31/12/96 | |
Director/Board Member | 58 | 11/08/20 | |
Director/Board Member | 62 | 31/07/20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 455,915,953 | 240,956,271 ( 52.85 %) | 0 | 52.85 % |
Company contact information
Lupin Ltd.
Kalpataru Inspire Off Western Expressway Highway
400055, Mumbai
+91 22 6640 2323
http://www.lupin.comGroup companies
Name | Category and Sector |
---|---|
Nanomi BV
Nanomi BV Chemicals: SpecialtyProcess Industries Part of Lupin Ltd., Nanomi BV is a Dutch company that manufactures drugs. The company is based in Oldenzaal, the Netherlands. Okke Franssen has been the CEO of the company since 2016. Nanomi was acquired by Lupin Ltd. on February 03, 2014. |
Chemicals: Specialty
|
Lupin Atlantis Holdings SA
Lupin Atlantis Holdings SA Pharmaceuticals: MajorHealth Technology Part of Lupin Ltd., Lupin Atlantis Holdings SA is a holding Swiss company that manufactures and distributes pharmaceutical products. The company is based in Zug, Switzerland. |
Pharmaceuticals: Major
|
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+54.61% | 811B | |
+44.25% | 640B | |
-6.33% | 353B | |
+20.62% | 333B | |
+10.44% | 302B | |
+18.45% | 246B | |
+2.09% | 225B | |
+13.03% | 218B | |
+8.61% | 168B |
- Stock Market
- Equities
- LUPIN Stock
- LUPIN Stock
- Company Lupin Limited